Steven M. Belknap

3.3k total citations
60 papers, 2.4k citations indexed

About

Steven M. Belknap is a scholar working on Toxicology, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Steven M. Belknap has authored 60 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Toxicology, 9 papers in Pharmacology and 9 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Steven M. Belknap's work include Pharmacovigilance and Adverse Drug Reactions (13 papers), Statistical Methods in Clinical Trials (8 papers) and Pharmaceutical studies and practices (7 papers). Steven M. Belknap is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (13 papers), Statistical Methods in Clinical Trials (8 papers) and Pharmaceutical studies and practices (7 papers). Steven M. Belknap collaborates with scholars based in United States, Lebanon and Italy. Steven M. Belknap's co-authors include Dennis W. Raisch, Charles L. Bennett, Dennis P. West, June M. McKoy, Paul R. Yarnold, Tsuen Ih Ruo, John E. Nelson, John Ambre, John W. Hafner and Andrew M. Evens and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Steven M. Belknap

55 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven M. Belknap United States 22 505 421 367 295 271 60 2.4k
Sebastian Harder Germany 34 549 1.1× 385 0.9× 1.0k 2.8× 214 0.7× 422 1.6× 109 3.5k
Daniel R. Morales United Kingdom 28 263 0.5× 307 0.7× 187 0.5× 363 1.2× 218 0.8× 83 2.3k
Walid Saliba Israel 31 466 0.9× 700 1.7× 701 1.9× 337 1.1× 348 1.3× 171 3.2k
Mitchell G. Scott United States 34 479 0.9× 363 0.9× 591 1.6× 489 1.7× 132 0.5× 112 3.7k
Mark de Groot Netherlands 24 350 0.7× 161 0.4× 263 0.7× 236 0.8× 129 0.5× 81 1.6k
Concetta Rafaniello Italy 28 267 0.5× 188 0.4× 265 0.7× 181 0.6× 438 1.6× 98 2.2k
Eric N. van Roon Netherlands 25 640 1.3× 255 0.6× 152 0.4× 148 0.5× 162 0.6× 92 2.0k
Eli D. Ehrenpreis United States 29 1.1k 2.2× 588 1.4× 92 0.3× 419 1.4× 553 2.0× 146 2.9k
Moro O. Salifu United States 26 479 0.9× 178 0.4× 330 0.9× 431 1.5× 130 0.5× 160 2.3k
A.‐P. Jonville‐Béra France 24 259 0.5× 164 0.4× 85 0.2× 139 0.5× 140 0.5× 136 1.8k

Countries citing papers authored by Steven M. Belknap

Since Specialization
Citations

This map shows the geographic impact of Steven M. Belknap's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven M. Belknap with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven M. Belknap more than expected).

Fields of papers citing papers by Steven M. Belknap

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven M. Belknap. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven M. Belknap. The network helps show where Steven M. Belknap may publish in the future.

Co-authorship network of co-authors of Steven M. Belknap

This figure shows the co-authorship network connecting the top 25 collaborators of Steven M. Belknap. A scholar is included among the top collaborators of Steven M. Belknap based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven M. Belknap. Steven M. Belknap is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Anthony, Lisa, et al.. (2017). Score of Toxic Epidermal Necrosis Predicts the Outcomes of Pediatric Epidermal Necrolysis. Pediatric Dermatology. 34(4). 433–437. 20 indexed citations
2.
Nardone, Beatrice, Anne E. Laumann, Beatrice J. Edwards, et al.. (2013). Pediatric nephrogenic systemic fibrosis is rarely reported: a RADAR report. Pediatric Radiology. 44(2). 173–180. 55 indexed citations
3.
McKoy, June M., Matthew J. Fisher, D. Mark Courtney, et al.. (2013). Results from the First Decade of Research Conducted by the Research on Adverse Drug Events and Reports (RADAR) Project. Drug Safety. 36(5). 335–347. 8 indexed citations
4.
Chang, Philip, Anne E. Laumann, Dennis P. West, et al.. (2012). Comparison of the Sensitivity of a Pre-MRI Questionnaire and Point of Care eGFR Testing for Detection of Impaired Renal Function. Academic Radiology. 19(10). 1181–1185. 6 indexed citations
5.
Allen, Katherine, Jonathan Cotliar, Steven M. Belknap, et al.. (2012). Anaphylaxis Associated with Administration of Repeated Courses of Rasburicase: A Research On Adverse Drug Events and Reports (RADAR) Project. Blood. 120(21). 1351–1351. 1 indexed citations
6.
Evens, Andrew M., Borko Jovanovic, Yu‐Chieh Su, et al.. (2010). Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports. Annals of Oncology. 22(5). 1170–1180. 256 indexed citations
7.
Belknap, Steven M., et al.. (2010). Quality of Methods for Assessing and Reporting Serious Adverse Events in Clinical Trials of Cancer Drugs. Clinical Pharmacology & Therapeutics. 88(2). 231–236. 15 indexed citations
8.
Belknap, Steven M., et al.. (2008). Application of Software Design Principles and Debugging Methods to an Analgesia Prescription Reduces Risk of Severe Injury From Medical Use of Opioids. Clinical Pharmacology & Therapeutics. 84(3). 385–392. 17 indexed citations
9.
Belknap, Steven M., Timothy M. Kuzel, Paul R. Yarnold, et al.. (2006). Clinical features and correlates of gemcitabine‐associated lung injury. Cancer. 106(9). 2051–2057. 45 indexed citations
10.
Nebeker, Jonathan R., Renu Virmani, Charles L. Bennett, et al.. (2005). Hypersensitivity Cases Associated With Drug-Eluting Coronary Stents. Journal of the American College of Cardiology. 47(1). 175–181. 457 indexed citations
11.
Bennett, Charles L., Stefano Luminari, Allen R. Nissenson, et al.. (2004). Pure Red-Cell Aplasia and Epoetin Therapy. New England Journal of Medicine. 351(14). 1403–1408. 284 indexed citations
12.
Patel, Shilpa M., Stuart Johnson, Steven M. Belknap, et al.. (2004). Serious Adverse Cutaneous and Hepatic Toxicities Associated With Nevirapine Use by Non???HIV-Infected Individuals. JAIDS Journal of Acquired Immune Deficiency Syndromes. 35(2). 120–125. 96 indexed citations
13.
14.
Belknap, Steven M.. (2002). Review: Studies on the cardiovascular effects of selective COX-2 inhibitors show mixed results. ACP Journal Club. 136(2). 53–53. 2 indexed citations
15.
Belknap, Steven M.. (2002). Review: studies on the cardiovascular effects of selective COX-2 inhibitors show mixed results. Evidence-Based Medicine. 7(2). 49–49. 4 indexed citations
16.
Hafner, John W., et al.. (2002). Adverse drug events in emergency department patients. Annals of Emergency Medicine. 39(3). 258–267. 148 indexed citations
17.
Belknap, Steven M.. (2001). Rate and rhythm control showed similar symptom improvement in atrial fibrillation. ACP Journal Club. 135(1). 14–14. 1 indexed citations
18.
Graumlich, James F., et al.. (2000). Pharmaceutical Care of Postoperative Nausea and Vomiting: Balanced Scorecard for Outcomes. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 20(11). 1365–1374. 8 indexed citations
19.
Varma‐Nelson, Pratibha, John E. Nelson, & Steven M. Belknap. (1991). Particle Concentration Fluorescence Immunoassay of Gentamicin. Therapeutic Drug Monitoring. 13(3). 260–262. 2 indexed citations
20.
Weinberg, Marc S., et al.. (1987). Effects of changing salt and water balance on renal kallikrein, kininogen and kinin. Kidney International. 31(3). 836–841. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026